Synergistic effect of TNF-α in soluble VCAM-1-induced angiogenesis through α4 integrins

Shintaro Nakao, Takashi Kuwano, Tatsuro Ishibashi, Michihiko Kuwano, Mayumi Ono

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

In our present study we focused on soluble VCAM-1 (sVCAM-1)/α4 integrin-induced angiogenesis and found that this type of angiogenesis was mediated through p38 mitogen-activated protein kinase and focal adhesion kinase (FAK). HUVEC expressed both α4 and β1 integrins, and it was reported that expression of α4 integrin and its counterreceptor, sVCAM-1/VCAM-1, was enhanced in response to an inflammatory cytokine, TNF-α. In endothelial cells phosphorylation of p38 and FAK, but not that of extracellular signal-regulated kinase 1/2 was induced by sVCAM-1. Migration of endothelial cells was stimulated in response to sVCAM-1 at similar levels as those induced by vascular endothelial growth factor, and sVCAM-1-induced migration was almost completely blocked by neutralizing Ab against α4 integrin, by either an inhibitor of p38 (SB203580), or by adenovirus containing FAK-related nonkinase. sVCAM-1 also induced the formation of blood vessels in Matrigel plug assay in vivo, and this neovascularization was blocked by SB203580 or neutralizing Ab against α4 integrin. Moreover, we also confirmed that both TNF-α and sVCAM-1 could synergistically induce angiogenesis in the corneas of mice when each factor at used dose could not induce. This angiogenesis by TNF-α and sVCAM-1 was almost completely blocked by coadministration of SB203580 and also by neutralizing Ab against α4 integrin. These results suggest that sVCAM-1/α4 integrin induces angiogenesis through p38 and FAK signaling pathways.

Original languageEnglish
Pages (from-to)5704-5711
Number of pages8
JournalJournal of Immunology
Volume170
Issue number11
Publication statusPublished - Jun 1 2003

Fingerprint

Vascular Cell Adhesion Molecule-1
Integrins
Focal Adhesion Protein-Tyrosine Kinases
Endothelial Cells
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
p38 Mitogen-Activated Protein Kinases
Adenoviridae
Cornea
Vascular Endothelial Growth Factor A
Blood Vessels
Phosphorylation
Cytokines

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Synergistic effect of TNF-α in soluble VCAM-1-induced angiogenesis through α4 integrins. / Nakao, Shintaro; Kuwano, Takashi; Ishibashi, Tatsuro; Kuwano, Michihiko; Ono, Mayumi.

In: Journal of Immunology, Vol. 170, No. 11, 01.06.2003, p. 5704-5711.

Research output: Contribution to journalArticle

Nakao, Shintaro ; Kuwano, Takashi ; Ishibashi, Tatsuro ; Kuwano, Michihiko ; Ono, Mayumi. / Synergistic effect of TNF-α in soluble VCAM-1-induced angiogenesis through α4 integrins. In: Journal of Immunology. 2003 ; Vol. 170, No. 11. pp. 5704-5711.
@article{a1408d1e945d4d05bed9236d92568e65,
title = "Synergistic effect of TNF-α in soluble VCAM-1-induced angiogenesis through α4 integrins",
abstract = "In our present study we focused on soluble VCAM-1 (sVCAM-1)/α4 integrin-induced angiogenesis and found that this type of angiogenesis was mediated through p38 mitogen-activated protein kinase and focal adhesion kinase (FAK). HUVEC expressed both α4 and β1 integrins, and it was reported that expression of α4 integrin and its counterreceptor, sVCAM-1/VCAM-1, was enhanced in response to an inflammatory cytokine, TNF-α. In endothelial cells phosphorylation of p38 and FAK, but not that of extracellular signal-regulated kinase 1/2 was induced by sVCAM-1. Migration of endothelial cells was stimulated in response to sVCAM-1 at similar levels as those induced by vascular endothelial growth factor, and sVCAM-1-induced migration was almost completely blocked by neutralizing Ab against α4 integrin, by either an inhibitor of p38 (SB203580), or by adenovirus containing FAK-related nonkinase. sVCAM-1 also induced the formation of blood vessels in Matrigel plug assay in vivo, and this neovascularization was blocked by SB203580 or neutralizing Ab against α4 integrin. Moreover, we also confirmed that both TNF-α and sVCAM-1 could synergistically induce angiogenesis in the corneas of mice when each factor at used dose could not induce. This angiogenesis by TNF-α and sVCAM-1 was almost completely blocked by coadministration of SB203580 and also by neutralizing Ab against α4 integrin. These results suggest that sVCAM-1/α4 integrin induces angiogenesis through p38 and FAK signaling pathways.",
author = "Shintaro Nakao and Takashi Kuwano and Tatsuro Ishibashi and Michihiko Kuwano and Mayumi Ono",
year = "2003",
month = "6",
day = "1",
language = "English",
volume = "170",
pages = "5704--5711",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Synergistic effect of TNF-α in soluble VCAM-1-induced angiogenesis through α4 integrins

AU - Nakao, Shintaro

AU - Kuwano, Takashi

AU - Ishibashi, Tatsuro

AU - Kuwano, Michihiko

AU - Ono, Mayumi

PY - 2003/6/1

Y1 - 2003/6/1

N2 - In our present study we focused on soluble VCAM-1 (sVCAM-1)/α4 integrin-induced angiogenesis and found that this type of angiogenesis was mediated through p38 mitogen-activated protein kinase and focal adhesion kinase (FAK). HUVEC expressed both α4 and β1 integrins, and it was reported that expression of α4 integrin and its counterreceptor, sVCAM-1/VCAM-1, was enhanced in response to an inflammatory cytokine, TNF-α. In endothelial cells phosphorylation of p38 and FAK, but not that of extracellular signal-regulated kinase 1/2 was induced by sVCAM-1. Migration of endothelial cells was stimulated in response to sVCAM-1 at similar levels as those induced by vascular endothelial growth factor, and sVCAM-1-induced migration was almost completely blocked by neutralizing Ab against α4 integrin, by either an inhibitor of p38 (SB203580), or by adenovirus containing FAK-related nonkinase. sVCAM-1 also induced the formation of blood vessels in Matrigel plug assay in vivo, and this neovascularization was blocked by SB203580 or neutralizing Ab against α4 integrin. Moreover, we also confirmed that both TNF-α and sVCAM-1 could synergistically induce angiogenesis in the corneas of mice when each factor at used dose could not induce. This angiogenesis by TNF-α and sVCAM-1 was almost completely blocked by coadministration of SB203580 and also by neutralizing Ab against α4 integrin. These results suggest that sVCAM-1/α4 integrin induces angiogenesis through p38 and FAK signaling pathways.

AB - In our present study we focused on soluble VCAM-1 (sVCAM-1)/α4 integrin-induced angiogenesis and found that this type of angiogenesis was mediated through p38 mitogen-activated protein kinase and focal adhesion kinase (FAK). HUVEC expressed both α4 and β1 integrins, and it was reported that expression of α4 integrin and its counterreceptor, sVCAM-1/VCAM-1, was enhanced in response to an inflammatory cytokine, TNF-α. In endothelial cells phosphorylation of p38 and FAK, but not that of extracellular signal-regulated kinase 1/2 was induced by sVCAM-1. Migration of endothelial cells was stimulated in response to sVCAM-1 at similar levels as those induced by vascular endothelial growth factor, and sVCAM-1-induced migration was almost completely blocked by neutralizing Ab against α4 integrin, by either an inhibitor of p38 (SB203580), or by adenovirus containing FAK-related nonkinase. sVCAM-1 also induced the formation of blood vessels in Matrigel plug assay in vivo, and this neovascularization was blocked by SB203580 or neutralizing Ab against α4 integrin. Moreover, we also confirmed that both TNF-α and sVCAM-1 could synergistically induce angiogenesis in the corneas of mice when each factor at used dose could not induce. This angiogenesis by TNF-α and sVCAM-1 was almost completely blocked by coadministration of SB203580 and also by neutralizing Ab against α4 integrin. These results suggest that sVCAM-1/α4 integrin induces angiogenesis through p38 and FAK signaling pathways.

UR - http://www.scopus.com/inward/record.url?scp=0037513467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037513467&partnerID=8YFLogxK

M3 - Article

C2 - 12759453

AN - SCOPUS:0037513467

VL - 170

SP - 5704

EP - 5711

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -